Lucid Diagnostics advanced payment, billing and coding pathways for EsoGuard and EsoCheck, including a proposed ICD-10-CM code, R85.83, for positive test results. The developments matter because they could support Medicare claims, physician reporting of EsoCheck procedures and documentation for confirmatory endoscopy once the relevant decisions and codes take effect.

Key Highlights

  • An AMA panel approved a new Category III CPT code for nonendoscopic esophageal cell collection performed with EsoCheck.
  • A proposed ICD-10-CM code, R85.83, received a positive response for reporting positive EsoGuard results tied to confirmatory upper endoscopy.
  • The recommendation applies to PLA code 0114U.
  • CMS is expected to make final determinations in November after public comment.

Medicare Payment and New Reporting Codes

The developments cover Medicare payment, physician reporting and diagnosis coding. The recommendation applies to PLA code 0114U, and a consent agenda reflecting it has been posted. The Centers for Medicare & Medicaid Services is expected to make final determinations in November after a public comment period. The AMA is expected to publish its meeting summary in the coming weeks.

Claims and Diagnosis Coding Pathways

The proposal received a positive response and is expected to proceed through a public comment process. The proposed code would support claims for subsequent confirmatory upper endoscopy by giving physicians a dedicated way to document the clinical rationale. Lucid (NASDAQ: LUCD) plans to begin submitting Medicare claims under PLA code 0114U for testing at its Texas laboratory this month.